LIAISON Ferritin
Ferritin, Antigen, Antiserum, Control. 510(k) K193650, from DiaSorin, Inc. (Stillwater, MN). Product code DBF, class 2.
As of Nov 17, 2026, K193650 is an FDA 510(k) held by DiaSorin, Inc., substantially equivalent on Sep 14, 2021 after 624 days, with no recalls tied to it in FDA's recall database.
- Substantially equivalent: Sep 14, 2021
- Review time: 624 days
- Recalls: 0
Indications for Use
As the 510(k) summary states them, read from FDA's summary PDFThe DiaSorin LIAISON® Ferritin assay is a quantitative automated chemiluminescent immunoassay (CLIA) for the in vitro detection of ferritin in human serum, serum separator tubes (SST), or lithium (Li) heparin plasma to aid in the diagnosis of iron deficiency anemia and iron overload. This assay must be performed on the LIAISON® XL Analyzer.
Predicate Devices
The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF- Elecsys FerritinK971833 · Boehringer Mannheim Corp. · Jun 2, 1997
Record
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Dec 30, 2019
- Review panel
- Immunology
- Regulation
- 21 CFR 866.5340
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files